Henry Meds vs IVIM Health vs Lavender Sky Health (2026)
On tirzepatide, the order is IVIM Health↗ ($278) → Henry Meds↗ ($349) → Lavender Sky Health↗ ($352) — gaps of $71 and then $3 a month, a $888 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
The three records, one screen
IVIM Health: the record, condensed
Start with the load-bearing figure: $278 a month, all-in, is what IVIM Health charges for tirzepatide at the 10 mg basis. Note the shape: $208 is the number in the marketing, $278 is the number at maintenance. The $70 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.
The all-in figure already contains a compulsory $75 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $203 would be exactly that kind of mirage.
To place the number: #3 of 17 verified programs, with the floor $63/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.
IVIM Health’s semaglutide program bills $149 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.
A required $75/month membership is part of the deal, and part of the figure above: $74 of medication plus $75 of platform equals the $149 that leaves your account. Judge the membership by what it includes, but compare on the total.
Context for that figure: it ranks #3 of 20 in the verified semaglutide index — $16/month above the floor (Oak Longevity, $133) — and sits $200 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $1,788.
Operationally at IVIM Health: shipping included; commitment membership mandatory for duration; cancellation membership mandatory; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the IVIM Health page · visit IVIM Health ↗
Henry Meds: the record, condensed
Start with the load-bearing figure: $349 a month, all-in, is what Henry Meds charges for tirzepatide at the 10 mg basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $349 is the whole subscription, which makes Henry Meds unusually easy to compare and unusually easy to leave.
To place the number: #10 of 17 verified programs, with the floor $134/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $100 a month. A year at this figure: $4,188 monthly-billed.
Start with the load-bearing figure: $179 a month, all-in, is what Henry Meds charges for semaglutide at the 2.4 mg basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
There is no membership line. $179 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.
Context for that figure: it ranks #9 of 20 in the verified semaglutide index — $46/month above the floor (Oak Longevity, $133) — and sits $170 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,148.
Operationally at Henry Meds: shipping included; commitment none month-to-month; cancellation check terms before prepaying; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Henry Meds page · visit Henry Meds ↗
Lavender Sky Health: the record, condensed
On tirzepatide, the number that matters at Lavender Sky Health is $352 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The structure is tiered: the advertised entry point is $200, but the maintenance figure — the one a full year is actually billed at — is $352. That $152 gap between the ad and the anniversary is the single most important line in this record.
A required $25/month membership is part of the deal, and part of the figure above: $327 of medication plus $25 of platform equals the $352 that leaves your account. Judge the membership by what it includes, but compare on the total.
To place the number: #12 of 17 verified programs, with the floor $137/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $97 a month. A year at this figure: $4,224 monthly-billed.
Start with the load-bearing figure: $174 a month, all-in, is what Lavender Sky Health charges for semaglutide at the 2.4 mg basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.
A required $25/month membership is part of the deal, and part of the figure above: $149 of medication plus $25 of platform equals the $174 that leaves your account. Judge the membership by what it includes, but compare on the total.
Context for that figure: it ranks #6 of 20 in the verified semaglutide index — $41/month above the floor (Oak Longevity, $133) — and sits $175 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,088.
Operationally at Lavender Sky Health: shipping included; commitment monthly plan fee recurs; cancellation plan fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Lavender Sky Health page · visit Lavender Sky Health ↗
Prices, gaps, and what sits inside them
IVIM Health holds the low ground at $278 (its $75 membership already inside). Henry Meds follows at $349 (+$71/mo, $852/yr). Lavender Sky Health tops the trio at $352 (+$74/mo over the leader, $888/yr) — note its record’s watch-out below.
The semaglutide picture reshuffles nothing: IVIM Health $149 → Lavender Sky Health $174 → Henry Meds $179 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.
Who wins what
Cheapest month-to-month: IVIM Health ($278); cheapest 12-month path: IVIM Health ($3,336); simplest billing (no membership): Henry Meds; dose-flat structure: Henry Meds; cheapest semaglutide of the three: IVIM Health ($149).
Every winner above is a computation, not a placement; the pairwise pages carry the full duels: IVIM Health vs Henry Meds · IVIM Health vs Lavender Sky Health (record · record) · Henry Meds vs Lavender Sky Health (record · record).
Everything besides the three prices
Memberships: IVIM Health $75/mo (inside its figure); Henry Meds none; Lavender Sky Health $25/mo (inside its figure). Structures: IVIM Health step/tiered; Henry Meds dose-flat; Lavender Sky Health step/tiered. Pharmacies: IVIM Health not named; Henry Meds not named; Lavender Sky Health not named. States: IVIM Health — not published; Henry Meds — most states; Lavender Sky Health — not published. Exit terms: IVIM Health — membership mandatory; Henry Meds — check terms before prepaying; Lavender Sky Health — plan fee recurs until cancelled.
The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: IVIM Health source-verified (2026-08-05); Henry Meds third-party reported (2026-08-05); Lavender Sky Health source-verified (2026-08-05).
The trio on semaglutide, across time
3 mo: IVIM Health $447 vs Lavender Sky Health $522 vs Henry Meds $537 6 mo: IVIM Health $894 vs Lavender Sky Health $1,044 vs Henry Meds $1,074 12 mo: IVIM Health $1,788 vs Lavender Sky Health $2,088 vs Henry Meds $2,148 — monthly-billed totals; prepaid paths where published appear on each provider page.
The trio, annualized
IVIM Health: $3,336/yr monthly-billed; Henry Meds: $4,188/yr monthly-billed; Lavender Sky Health: $4,224/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,776 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.
The elimination read
A three-way choice is really two eliminations, so run them in order. Eliminate Lavender Sky Health first unless it names its edge: at $352 it carries a $74/month premium over the floor of this trio — $888 a year, about 3.2 extra months of therapy at IVIM Health’s rate — and a premium that size must point at a specific line in its record (the services inside its $25/mo membership) or it is decoration. Then interrogate Henry Meds’s middle ground: its dose-flat structure removes titration repricing; if that specific thing is on your personal ledger, the $71/month over the floor can be rational — if not, the middle is where budgets go to leak. What survives is IVIM Health at $278, which wins by default rather than by argument — exactly how a price index should crown things — subject to the two checks no ranking can run for you: your state at intake, and your prescriber on the medication itself.
The same trio on best published rate: IVIM Health $278 → Henry Meds $349 → Lavender Sky Health $352 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — IVIM Health $834, Henry Meds $1,047, Lavender Sky Health $1,056; 6 months — IVIM Health $1,668, Henry Meds $2,094, Lavender Sky Health $2,112. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.
The record-quality read, scored on the five checkable disclosures this index tracks (maintenance price, named pharmacy, published states, published cancellation terms, source-verified capture): IVIM Health 4/5, Henry Meds 3/5, Lavender Sky Health 4/5. IVIM Health discloses the most and Henry Meds the least, and in this market disclosure predicts disclosure — the axis where a program goes quiet is reliably where its checkout surprises live. The three match on every disclosure axis, which is rare and worth noting in their favor collectively. Scores recompute from the public records like everything else here.
Read as a decision: start from IVIM Health and make the other two argue upward. Henry Meds’s case is its structure; Lavender Sky Health’s case must be worth $888 a year in named features — the honest unit being months of medication (3.2 of them at the floor rate). The pairwise pages above hold each argument in full, and the calculator holds your version of it.
Frequently asked
Which is cheapest: Henry Meds, IVIM Health, or Lavender Sky Health?
IVIM Health, at $278/month all-in tirzepatide — $71 under Henry Meds and $74 under Lavender Sky Health; on semaglutide the cheapest of the three is IVIM Health at $149. Captured 2026-08-09.
Which of the three is best over a full year?
IVIM Health’s best path prices twelve months at $3,336; monthly-billed years run IVIM Health $3,336, Henry Meds $4,188, Lavender Sky Health $4,224.
Are these rankings paid or editorial?
Neither — they are sorts of the public dataset on the all-in maintenance basis, regenerated on every data change; the methodology page defines the basis and the JSON lets you recompute every figure here.